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Knockdown of death receptor 5 antisense long noncoding RNA and cisplatin treatment
modulate similar macromolecular and metabolic changes in HeLa cells
1

1

2,

1,

Dilek Cansu GÜRER , İpek ERDOĞAN VATANSEVER , Çağatay CEYLAN *, Bünyamin AKGÜL *
1
Noncoding RNA Laboratory, Department of Molecular Biology and Genetics, Faculty of Science,
İzmir Institute of Technology, İzmir, Turkey
2
Department of Food Engineering, Faculty of Engineering, İzmir Institute of Technology, İzmir, Turkey
Received: 17.08.2022

Accepted/Published Online: 05.12.2022

Final Version: 19.12.2022

Background/aim: Despite great progress in complex gene regulatory mechanisms in the dynamic tumor microenvironment, the
potential contribution of long noncoding RNAs (lncRNAs) to cancer cell metabolism is poorly understood. Death receptor 5 antisense
(DR5-AS) is a cisplatin inducible lncRNA whose knockdown modulates cell morphology. However, its effect on cell metabolism is
unknown. The aim of this study is to examine metabolic changes modulated by cisplatin and DR5-AS lncRNA in HeLa cells.
Materials and methods: We used cisplatin as a universal cancer therapeutic drug to modulate metabolic changes in HeLa cervix
cancer cells. We then examined the extent of metabolic changes by Fourier transform infrared spectroscopy (FTIR). We also performed
transcriptomics analyses by generating new RNA-seq data with total RNAs isolated from cisplatin-treated HeLa cells. Then, we compared
cisplatin-mediated transcriptomics and macromolecular changes with those mediated by DR5-AS knockdown.
Results: Cisplatin treatment caused changes in the unsaturated fatty acid and lipid-to-protein ratios and the glycogen content. These
observations in altered cellular metabolism were supported by transcriptomics analyses. FTIR spectroscopy analyses have revealed that
DR5-AS knockdown causes a 20.9% elevation in the lipid/protein ratio and a 76.6% decrease in lipid peroxidation. Furthermore, we
detected a 3.42% increase in the chain length of the aliphatic lipids, a higher content of RNA, and a lower amount of glycogen indicating
relatively lower metabolic activity in the DR5-AS knockdown HeLa cells. Interestingly, we observed a similar gene expression pattern
under cisplatin treatment and DR5-AS knockdown HeLa cells.
Conclusion: These results suggest that DR5-AS lncRNA appears to account for a fraction of cisplatin-mediated macromolecular and
metabolic changes in HeLa cervix cancer cells.
Key words: HeLa cells, DR5-AS, cisplatin, FTIR spectroscopy, cancer, metabolism, transcriptomics

1. Introduction
lncRNAs are transcripts of over 200 nucleotides (nt) in
length that do not harbor any open reading frames (ORF)
greater than 100 amino acids (aa) (Yao et al., 2019). lncRNAs
are produced from quite versatile genomic loci following a
complex biogenesis process in eukaryotic cells (Cao et al.,
2018). As transcriptional and posttranscriptional regulators
of gene expression, lncRNAs are involved in numerous
cellular processes in health and disease, including cancer
(DiStefano, 2018). lncRNAs function through one of
four ways, including molecular signals, scaffolds, decoys
and guides (Qian et al., 2020). Any deregulation in these
molecular functions results in activation or suppression
of numerous cancer-related signalling pathways (Erdogan
et al., 2022). For example, HOTAIR promotes the cervical

cancer progression by sponging miR-143-3p, which leads
to enhanced proliferation and suppressed apoptosis
through modulation of BCL2 expression (Liu et al., 2018).
H19, which is highly expressed in cervical cell lines, has
been reported to promote both anchorage-dependent
and –independent growth without affecting apoptosis
(Iempridee 2017). MALAT1 expression correlates well
with the tumor size while its knockdown in cervical
cancer cells leads to reduced proliferation and enhanced
apoptosis (Yang et al., 2015). Additionally, many other
lncRNAs have been shown to contribute to cervix cancer
progression (Cáceres-Durán et al., 2020). Accumulating
evidence clearly shows that numerous protein-coding
genes play an instrumental role in orchestrating cancer
cell metabolism under adverse conditions such as drug
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treatment (Martínez-Reyes and Chandel, 2021). Recently,
emerging studies point to the vital role of lncRNAs in this
process (Ghafouri-Fard et al., 2020).
We have recently reported that cisplatin, a universal
chemotherapeutic drug (Rosenberg et al., 1965),
induces a number of lncRNAs in HeLa cells (Gurer et
al., 2021). Knockdown of death receptor 5 antisense
(DR5-AS) lncRNA, one of those cisplatin-inducible
lncRNAs, causes a morphological change in HeLa cells
accompanied with a reduction in cell proliferation and
metastasis. Despite a genomic overlap between DR5-AS
and DR5, the knockdown or ectopic overexpression of
DR5-AS is not sufficient to modulate the DR5 mRNA
abundance or TRAIL-mediated apoptosis. Based on
these transcriptomics and cellular data, DR5-AS has been
proposed to account for some of the effects of cisplatin in
HeLa cells (Gurer et al., 2021). However, it is unknown
whether DR5-AS modulates cancer cell metabolism,
similar to cisplatin, possibly linked to the proliferative or
metastatic state of HeLa cells.
Fourier transform infrared spectroscopy (FTIR) is a
noninvasive and rapid spectroscopic method for sensitive
analysis of changes in biological systems at the functional
group level. The spectra obtained can be processed through
several digital manipulations to yield both qualitative
and quantitative information based on the changes in
bandwidths, intensities and band positions (Dogan et al.,
2007; Cakmak et al., 2007). FTIR has several advantages
such as, simultaneous measurement of spectral elements,
a greater signal-to-noise ratio, and a greater optical
throughput (Nguyen, 1985). Limitations of FTIR include
difficulty in interpretation of interferograms, the spread
of a local noise throughout the spectrum and the use of a
single beam. FTIR is commonly used to measure changes
in the concentration and composition of macromolecules,
which provide valuable insight into disease- and drugspecific alterations (Manoharan et al., 1993; Ci et al., 1999)
such as cancer metabolism or drug resistance (Wu et al.,
2015).
In this study, we first used cisplatin as a universal
chemotherapeutic drug to examine the extent of
cisplatin-mediated metabolic changes in HeLa cervix
cancer cells. FTIR analyses showed that cisplatin causes
major metabolic changes in the unsaturated fatty acid
ratio, lipid-to-protein ratio, glycogen and RNA contents.
Transcriptomics analyses of cisplatin-treated cells
supported these observations as revealed by deregulation
of 1367 metabolic genes. Interestingly, knockdown of DR5AS lncRNA in HeLa cells caused similar changes in the
macromolecule patterns as revealed by FTIR spectroscopy
analysis and perturbed the expression of similar metabolic
genes albeit to a lesser extent. Bioinformatics analyses
suggest that both cisplatin- and DR5-AS-knockdown-

mediated changes appear to be orchestrated primarily by
the PI3K signaling.
2. Materials and methods
2.1. Cell culture, transfection and cisplatin treatment in
HeLa cells
Cell culture, transfection and cisplatin treatments were
performed essentially as described previously (Gurer
et al., 2021). Transfected cells were also subjected to
crystal violet staining. Prior to cell imaging, transfected
cells were fixed with cold methanol (100%) followed by
staining with 0.1% crystal violet (Sigma, United States).
Cells were incubated in dark at room temperature for
five min. The excess dye was washed off under running
tap water. Then the samples were air-dried and visualized
under a brightfield microscope. To quantitatively measure
the rate of apoptosis, three biological replicates were first
trypsinized by 1X Trypsin-EDTA (Gibco, United States)
and washed in 1X cold PBS (Gibco, United States). The
cells were then resuspended in 1X Annexin binding
buffer (Becton Dickinson, United States) and stained
with Annexin V-PE (Becton Dickinson, United States)
and 7AAD (Becton Dickinson, United States) prior to
incubation for 15 min in dark at room temperature.
The stained cells were analyzed by FACSCanto (Becton
Dickinson, United States). Annexin V-positive cells were
considered early apoptotic. A fraction of cells was stored
at –80 °C for FTIR until use, while the rest was used for
RNA isolation.
2.2. Total RNA isolation, RNA-seq and qPCR
Manufacturer’s instructions were followed to isolate total
RNAs from control DMSO- and cisplatin-treated HeLa
cells, using TRIzol (Life Technologies, United States).
TURBO DNA-freeTM kit (Invitrogen, United States)
was used to eliminate trace amounts of genomic DNA
contamination from RNA samples.
RNA sequencing and bioinformatics analyses of
control- and cisplatin-treated cells were performed
essentially as described previously (Gurer et al., 2021).
Briefly, libraries were prepared from five μg total RNAs by
the poly(A) capture method (n = 3) and were sequenced
by an Illumina HiSeq2500 (FASTERIS, Switzerland,
https://www.fasteris.com/dna/). RNA-seq data obtained
from cisplatin-treated HeLa cells were deposited into the
Gene Expression Omnibus under the accession number
GSE193447. RNA-seq data obtained from DR5-AS
knockdown HeLa cells were reported previously under
the accession number GSE160227 (Gurer et al., 2021).
The following tools and the command lines were used in
the conda environment (Grüning et al., 2018) to analyze
RNA-seq data: FastQC (fastqc -o <output_directory> –
noextract <filename>) (Andrews 2010); Trim Galore!
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(trim_galore --quality 20 --fastqc --length 25 --output_
dir <output_directory> <input_file>) (Krueger 2015);
SortMeRNA (sortmerna –ref <reference_rRNA_sequence>
--reads <trimmed_fastqc_file> --aligned <output_for_
aligned_reads> --other <filtered_reads> --fastx –threads
10 –v) (Kopylova et al., 2012); STAR (STAR –genomeDir
<index_path> --readFilesIn <trimmed&filtered_reads>
--outFileNamePrefix <sequence_name> --outSAMtype
BAM SortedByCoordinate –quantMode GeneCounts)
(Dobin et al., 2013); featureCounts (featureCounts -O -a
<annotation_file> -o <output_path/final_counts.txt> -g
‘gene_id’ -T 8 <list_of_BAM_files>) (Liao et al., 2014); and
MultiQC (by using multiqc <results_directory> --outdir
<output_directory>) (Ewels et al., 2016). Differential
gene expression analyses were performed by DESeq2
and pheatmap package in R (Durinck et al., 2009; Love
et al., 2014). DESeq2 analyses were carried out with
default parameters (Wald test). The results function was
used with FDR for pAdjustMethod with a cutoff value of
0.05. Subsequently, significant results were filtered with

a treshold of padj < 0.05. Finally, gene names, biotypes
and gene descriptions were annotated via a custom code
in R by using the dplyr package. Pathway Enrichment
Analysis was performed with the Reactome database to
identify biological processes associated with differentially
expressed genes (Jassal et al., 2020). The resulting data was
visualized with ggplot2 package in R platform (Wickham
2006). qPCR reactions were carried out as described
previously (Gurer et al., 2021). GAPDH was used for
normalization. qPCR primer sequences are listed in Table.
2.3. Fourier transform infrared spectroscopy (FTIR)
measurements
Control, treated and transfected HeLa cells were
lyophilized in a freeze drier (Labconco, FreeZone 18 L
freeze dry system) overnight to remove water. The FTIR
spectra of the samples were recorded in the 4000 and 450
cm–1 region for 20 scans at 4 cm–1 resolution using a Perkin
Elmer spectrometer equipped with MIR TGS detector
(Spectrum 100 Instrument, PerkinElmer Inc., Norwalk,
CT, USA). Normalization (e.g., PO2 symmetric streching

Table. Primer sequences that were used in this study.
Gene Name

Gene Symbol Forward 5’-3’

Reverse 5’-3’

Uncoupling Protein 3
Solute Carrier Family 25
Member 27
CDP-Diacylglycerol Synthase 1
3-Hydroxy-3-MethylglutarylCoA Synthase 1
Acyl-CoA Dehydrogenase Short
Chain
Acetyl-CoA Carboxylase Beta

UCP3

GGTCTCACCTCTAGACAACCG

GGACAATGCCTTGGGAGAGA

SLC25A27

CAGCTACATACCACCGGCTC

TCCATAACCGCAGCCATCC

CDS1

ACTCACCTCGCAAGAAGGAAG

GGAGCAAGGGGACAAAGATGA

HMGCS1

AATGCCCTGCCCCTATTCTT

GTTGCAGTCCTTCTTTGCACC

ACADS

GGCAGTTACACACCATCTACCA

CGGCATGTCTGGAGCAACA

ACACB

TGGAGGGCCACTTGAGTTAC

CAGTCCAGTCCTCAGTCACC

Stearoyl-CoA Desaturase 5

SCD5

TCCCCCTTCTGTCTTCTACCC

TCAGTGTAGTTCAGGAGAGCATTT

Proline Rich 5

PRR5

CACCTGCCCACAGAGAATGTA

GTGCTGGAGTCTGGTCACTT

Tribbles Pseudokinase 3

TRIB3

CTGGCATCCTTGAGCTGACA

AGGCCGACACTGGTACAAAG

Rac Family Small GTPase 2
Nuclear Receptor Subfamily 4
Group A Member 1
Phosphatidylinositol-4Phosphate 5-Kinase Type 1 Beta
Phosphatidylinositol-5Phosphate 4-Kinase Type 2
Alpha

RAC2

GATGGTGTCCTTGTCGTCCC

CACCACTGCCCCAGCAC

NR4A1

GGTGACCCCACGATTTGTCT

GGCTTATTTACAGCACGGCG

PIP5K1B

TTGCTGTTGCTTGCTGAACTG

AGCACTTCCAACTCCAAAAAGG

PIP4K2A

CCTGAACCAGTACACACGGA

ACGCAGACACTCTCCCTAAC

ADCY6

CAGACAGACAGGGAAGGGTAGG

GAGGGGTCAGTAGCAGAAGCA

ITPR2

CAGCAGAAACTGATACTTTTGAACC ATGCAATCATCTTGAACTTTGATGT

PRKAR2B

AGTTGCCCTGTTTGGAACGA

TGTCACTACAGGTCTTGCTCC

RPN2

TCCCCAACACACAGCAGATAC

AAGCAACATCTGGGTAAGTTAGGA

Adenylate Cyclase 6
Inositol 1,4,5-Trisphosphate
Receptor Type 2
Protein Kinase CAMPDependent Type II Regulatory
Subunit Beta
Ribophorin II
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band) was performed according to a previously published
procedure (Baran et al. 2013). The spectral data were
analyzed using the Spectrum 100 software (PerkinElmer).
The automatically baseline-subtracted spectra were
then averaged for both control versus knockdown or
treatment groups (n = 3). The spectra were normalized
after baselining from two arbitrarily selected points for
each analyzed region for the visual demonstration and
comparison.
2.4. Statistical tests
The results are expressed as mean +/– standard deviation.
The control and DR5-AS knockdown or treated Hela cells
were statistically compared with the Mann–Whitney U
test. The degree of significance was denoted as p < 0.05.
For qPCR analyses of DMSO versus cisplatin treatments
and negative GapmeR- versus DR5-AS GapmeRtransfected HeLa cells, unpaired t-test were conducted
with a confidence level of 95%, p < 0.05.
3. Results
3.1. FTIR identifies macromolecular and metabolic
changes in cisplatin-treated HeLa cells
We used FTIR spectroscopy to inspect the cisplatinmediated macromolecular and metabolic changes in HeLa
cells (Dogan et al., 2013; Lopes-Rodrigues et al., 2017;
de Magalhães et al., 2020). To this extent, we first treated
HeLa cells with cisplatin as previously published (Gurer
et al., 2021). Cisplatin at a concentration of 80 µM led to
an early apoptotic rate of 43% (Figures 1A–1C). We then
subjected three biological replicates of cisplatin-treated
HeLa cells to FTIR analyses. The FTIR spectrum of HeLa
cells exhibited several bands representing changes in
different macromolecular functional groups. The region
between 2800 cm–1 and 3700 cm–1 was used to analyze
lipid and protein contents while the region between 890
cm–1 and 1478 cm–1 (the fingerprint region) was used for
the analysis of nucleic acids, glycogen, lipids, and proteins.
2800–3012 cm–1 region: The FTIR spectrum in
this region consists of CH3 and CH2 symmetric and
asymmetric stretching vibrations. The band around
3006 cm–1 is an indicator of unsaturated fatty acids and
denotes olefinic (C=C) bond stretching (Ozek et al.,
2010) as shown in Figures 1D–1E. Since double bonds
are oxidized via lipid peroxidation reactions, this band is
also used as an indicator of the level of lipid peroxidation
in cell and tissue culture-based studies (Ceylan et al.,
2012). The intensity of this band decreased from 0.01283
(+/– 0.001773) to 0.011987 (+/– 0.000751) (p = 0.366) in
cisplatin-treated HeLa cells, suggesting a 6.57% decrease
in lipid peroxidation (Figures 1D–1E). Additionally, we
used the intensity ratio of CH2 symmetric/CH3 symmetric
stretching to estimate the lipid-to-protein ratio (Dogan et

al., 2007) This ratio was 1.0769 (+/– 0.0515) and 1.3018
(+/– 0.0517) (p = 0.0012) in DMSO control and cisplatintreated HeLa cells, respectively, pointing to a 20.9% increase
in the lipid-to-protein ratio in cisplatin-treated HeLa cells
(Figures 1D–1E). The intensity ratio of CH2 asymmetric/
CH3 asymmetric stretching was used as an indicator of
hydrocarbon chain length of the lipid acyl chains (Gupta
et al., 2014; Mylonis et al., 2019). This ratio was found to
be 1.6910 (+/– 0.0164) for the cisplatin-treated HeLa cells
and 1.48 (+/– 0.063) (p = 0.0012) for their control cells,
suggesting a 14.39% increase in cisplatin-treated HeLa
cells when compared to the control cells.
Fingerprint Region: The spectral region included
several bands representing nucleic acids, glycogen,
lipids, and proteins. The most striking cisplatin-mediated
alterations within this region were centered between 1181
cm–1 and 890 cm–1 with peaks originating from basically
nucleic acids and glycogen. Although the band at 1082
cm–1 depicting PO2 symmetric stretching of nucleic acids
did not show any significant changes, the PO2 asymmetric
stretching of nucleic acids band shifted from 1234.46
cm–1 (+/– 1.88) to 1235.73 cm–1 (+/– 0.73) (p = 0.18) in
cisplatin-treated HeLa cells (Figures 1D–1E).
Attributes to cellular glycogen contents may be
obtained by changes in the intensity of the band at 996 cm–1
(Wiercigroch et al., 2017). This band displayed a 7.03%
decrease in cisplatin-treated HeLa cells. The other glycogen
band characteristic of cancer cells (Wong et al., 1991) is
around 1156 cm–1. We observed a decrease in the intensity
of this band indicating reduction in the glycogen content
of cisplatin-treated HeLa cells (Figures 1D–1E). The band
at 1171 cm–1 is ascribed to C-O stretching of proteins in
cancer cells (Rigas et al., 1990) and CO-O-C stretching of
cholesterol. The intensity of this band increased by 31.29%
in cisplatin-treated HeLa cells. The absorption around
1121 cm–1 belongs to RNA. Based on this spectrum, we
observed 2.69% higher RNA content in cisplatin-treated
HeLa cells when the band was normalized against the PO2
symmetric stretching band at 1083 cm–1 (Figures 1D–1E).
3.2. Cisplatin treatment perturbs the abundance of
metabolic genes
Although previous studies showed the potential effect
of cisplatin on metabolic genes in some cancer cells
(Shirmanova et al., 2017; Miyazawa et al., 2019), a
complete and in-depth profile of these genes in HeLa cells
is not available yet. We employed the RNA sequencing
approach to gain insight into the molecular mechanism of
cisplatin-induced macromolecular and metabolic changes
detected in HeLa cells through FTIR analyses (Figure 1).
To this extent, we subjected three biological replicates
of cisplatin-treated HeLa cells to RNA sequencing. We
first checked the accuracy of data normalization. The
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Figure 1. Cisplatin-induced apoptosis and metabolic changes in HeLa cells. 1X106 HeLa cells were treated with 80 μM cisplatin (CP)
and control 0.1% (v/v) DMSO for 16 h and analyzed by flow cytometry following staining with Annexin V-PE and 7AAD. Dot blots of
(A) DMSO control and (B) cisplatin-treated cells were used to calculate the percentage of live and early apoptotic populations in (C).
Q3 and Q4 quadrants depict live and early apoptotic cells, respectively. (D–E) FTIR spectra of the control (0.1% DMSO, solid line) and
cisplatin-treated group (dotted line), respectively. The spectra were normalized with respect to the CH2 asymmetric mode (observed
at 2924 cm–1) for the region between 3000–2800 cm–1 (D) and PO22- symmetric mode (observed at 1082 cm–1) for the region between
1181–894 cm–1 (E), respectively. ****: p ≤ 0.0001.

MA plot showed that the RNA-seq data was normalized
accurately (Supplementary Figure 1A). Our analyses
yielded the differential expression of 16,452 transcripts,
8490 and 7962 of which were up- and down-regulated,
respectively (Figures 2A–2B; Supplementary Table 1). We
then carried on our analyses with 11,428 protein coding
genes using the Gene Ontology and the Reactome pathway
analysis tools (Jassal et al., 2020) to identify the biological
processes primarily affected by cisplatin treatment
(Figure 2C). Interestingly, metabolism is situated on top
of the list sorted by GeneRatio. (Figure 2C), denoting the
potential significance of cellular metabolism in cisplatin’s
therapeutic effects. Gene ontology analysis results are
presented in Supplementary Table 2. We then used the
gene list sorted by the Reactome pathway analysis tool to
interrogate which metabolic pathways are mainly affected
by cisplatin treatment. Our analyses showed perturbations
in protein metabolism (1326 genes), lipid metabolism
(534 genes), RNA metabolism (512 genes), carbohydrate
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metabolism (207 genes) and glycogen metabolism (18
genes) (Figure 3D). We then selected these metabolic
genes and performed another Reactome pathway analysis
to uncover the signal transduction pathways associated
with these metabolic genes. Our analysis revealed that 74
out of 1367 metabolic genes are linked with intracellular
signaling with secondary messengers, e.g., PI3K (Figure
2E). All of these genomics analyses were validated by
qPCR through the selection of a set of genes. Strikingly,
there was a high congruity between RNA-seq and qPCR
results (Figure 2F).
3.3. FTIR identifies macromolecular and metabolic
changes in DR5-AS knockdown cells
It is well-documented that many protein-coding genes
participate in the regulation of cancer cell metabolism
(Pavlova and Thompson 2016). However, the potential
role of long noncoding RNAs is only being embraced
recently (Ghafouri-Fard et al., 2020). We have previously
reported that cisplatin modulates the abundance of
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Figure 2. Transcriptomics analyses of cisplatin-treated HeLa cells. Total RNAs were isolated from three biological replicates of HeLa cells treated with 80 μM cisplatin and 0.1%
DMSO as explained in Figure 1. The sequencing library was generated by the poly(A) capturing method and then sequenced with HiSeq 2500. Raw sequences were processed with
the following tools in conda environment; quality check by FastQC, adapter trimming by Trim Galore!, rRNA contamination removal by SortMeRNA, reference genome alignment
by STAR and read counting by featureCounts. Then the count matrix was subjected to differential expression analysis by DESeq2 in R. Only statistically significant ones (p < 0.05)
were used for further analyses. (A) Heatmap of top 1000 differentially expressed genes (DEGs) in DMSO control and cisplatin-treated HeLa cells. (B) Volcano-plot of RNA-seq data
analysis. (C) Reactome pathway analysis of differentially expressed protein-coding genes in cisplatin-treated HeLa cells. First 30 pathways were taken into account based on the
GeneRatio values. (D,E) Reactome pathway analyses of other metabolic pathways associated with DEGs in cisplatin-treated HeLa cells and signal transduction pathways associated
with metabolism-related DEGs, respectively. (F) qPCR analyses of differentially expressed metabolism-related genes. 1000 ng of RNA were used for cDNA synthesis and GAPDH
was used for normalization. ns: nonsignificant, p > 0.05, *: p ≤ 0.05, **: p ≤ 0.01, ***: p ≤ 0.001, ****: p ≤ 0.0001.
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numerous lncRNAs in HeLa cells (Gurer et al., 2021).
Interestingly, DR5-AS, one of those cisplatin inducible
lncRNAs, partially accounts for some of the pleiotropic
effects of cisplatin in HeLa cells, such as cell morphology,
proliferation, and metastasis (Gurer et al., 2021). We
hypothesized that DR5-AS could also modulate some, if not
all, of cisplatin-mediated macromolecular and metabolic
changes in HeLa cells. To this extent, we first knocked
down DR5-AS using the GapmeR technology (Gurer
et al., 2021). The qPCR analyses of total RNAs isolated
from control and DR5-AS knockdown cells showed that
DR5-AS could be knocked down by 82% (Figure 3A). We
then examined the hexamethyl pararosaniline chloride
(crystal violet) staining pattern of DR5-AS knockdown
HeLa cells as this basic dye with high affinity for acidic
intense chromatin structures during cell division can
bind and stain both DNA and proteins. The microscopic
analyses of knockdown cells stained with crystal violet
exhibited a dramatic change in cell morphology and an
intense staining pattern of dividing cells (Figures 3B–3C),
suggesting cell viability, yet disturbed proliferation and
probably metabolic changes (Kadoo et al., 2018).
We then examined the FTIR spectra of DR5-AS
knockdown HeLa cells to identify macromolecular
changes in morphologically disturbed cells for comparison
with cisplatin-treated HeLa cells. The band around 3006
cm–1 decreased from 0.03181 (+/– 0.039) to 0.00747
(+/– 0.000701) for DR5-AS knockdown HeLa cells,
exhibiting a 76.6% decrease in lipid peroxidation in DR5AS knockdown HeLa cells (Figures 3D–3E). The intensity
ratio of CH2 symmetric/CH3 symmetric stretching, which
is used to estimate the lipid/protein ratio (Dogan et al.,
2007), increased to 1.3018 in DR5-AS knockdown HeLa
cells compared to 1.076 in control HeLa cells indicating a
20.9% increase (p = 0.0173) (Figures 3D–3E). Additionally,
the intensity ratio of CH2 asymmetric/CH3 asymmetric
stretching was used as an indicator of the hydrocarbon
chain length of the lipid acyl chains (Gupta et al., Mylonis
et al., 2019). This ratio was found to be 1.630 (+/– 0.030)
for the DR5-AS knockdown HeLa cells and 1.5359 (+/–
0.1186) (p = 0.0173) for their control cells. Based on
this ratio, we calculated a 6.5% increase in the DR5-AS
knockdown HeLa cells when compared to the control cells.
In the fingerprint region, the band at 1082 cm–1, which
represents PO2 symmetric stretching of nucleic acids,
shifted from 1080.92 (+/– 1.71) cm–1 to 1083.09 (+/– 0.33)
cm1 (p = 0.026) in DR5-AS knockdown HeLa cells. In
addition, the PO2 asymmetric stretching of nucleic acids
band shifted from 1234.52 cm–1 (+/- 0.41) to 1235.47
(+/-0.45) (p = 0.0152) in DR5-AS knockdown HeLa cells
(Figures 3D–3E). The band at 996 cm–1, which is attributed
to the cellular glycogen content (Wiercigroch et al., 2017),
almost vanished in DR5-AS knockdown HeLa cells. The

494

other glycogen band characteristic of cancer cells (Wong
et al., 1991) is present at 1156 cm–1, which also decreased
in intensity indicating a decrease in the glycogen content
of DR5-AS knockdown cells. The band at 1171 cm–1 is
ascribed to C-O stretching of proteins in cancer cells
(Rigas et al., 1990) and CO-O-C stretching of cholesterol.
The intensity of this band increased by 9.66% in the DR5AS knockdown HeLa cells.
One of the most important changes in the spectra is the
subtle increase in the RNA content of DR5-AS knockdown
cells as depicted by the intensity of the band at 1121 cm–1
(Ozek et al., 2010). Our calculations indicate a 16.68%
higher RNA content in DR5-AS knockdown HeLa cells
when the band was normalized with respect to the PO2
symmetric stretching band at 1083 cm–1 (Figures 3D–3E).
3.4. Expression patterns of metabolic genes are similar
in DR5-AS knockdown and cisplatin-treated HeLa cells
The FTIR spectra of DR5-AS knockdown and cisplatintreated HeLa cells suggest that at least a fraction of
cisplatin-mediated metabolic changes could be accounted
for by DR5-AS. To solidify these observations, we
reexamined the previously published RNA-seq data
obtained from DR5-AS knockdown cells (Gurer et al.,
2021). Our analyses revealed the differential expression of
256 genes (51 upregulated, 152 downregulated) associated
with metabolism in DR5-AS knockdown HeLa cells
(Figure 4A). When we fed these metabolic genes into
the Reactome pathway analysis tool, we discovered the
intracellular signaling by second messengers to be on
top of the list, parallel to our findings in cisplatin-treated
HeLa cells (Figure 4B). Interestingly, DR5-AS knockdown
modulated the abundance of 185 out of 256 metabolic
genes parallel to cisplatin treatment (40 upregulated,
145 downregulated) (Figure 4C; Supplementary Table
3). Pearson correlation analysis further supported their
moderate positive correlation (Supplementary Figure
1B, r = 0.72, p < 0.05). We then selected some of the key
metabolic genes for qPCR validation. As expectedly, qPCR
results were highly congruous with the RNA-seq data
(Figure 4D).
4. Discussion
A complex interaction among various types of cells in
the tumor microenvironment (TME) contributes to the
overall cancer cell metabolism (Lau and Vander Heiden
2020), which can be targeted for cancer chemotherapy by
using several different chemical agents. Although cisplatin
has been used in the treatment of various cancers for long,
its effect on HeLa cell and other cancer cell metabolism
is partially investigated. Recently, FTIR analyses have
been successfully employed to investigate the molecular
structure, reactivity, and cytotoxicity of cisplatin (Wang et
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Figure 3. DR5-AS knocked-down cells have altered metabolism. (A) qPCR analyses were conducted with total RNAs isolated from
negative and DR5-AS-GapmeR-transfected HeLa cells. 75,000 cells/well were employed for GapmeR-assisted transfection in a 6-well
format. GapmeR concentration was 40 nM, and the cells were incubated for 72 h. Experiments were conducted in triplicates. (B, C)
Brightfield images of negative GapmeR- and DR5-AS GapmeR-transfected HeLa cells, respectively, after crystal violet staining. (D,
E) FTIR spectra of the control (negative GapmeR- solid line) and DR5-AS GapmeR-transfected group (dotted line), respectively. The
spectra were normalized with respect to the CH2 asymmetric mode (observed at 2924 cm–1) for the region between (D) 3000–2800
cm–1 and PO22- symmetric mode (observed at 1082 cm–1) (E) for the region between 1181–894 cm–1, respectively. ****: p ≤ 0.0001.

al., 2015; Farhadi et al., 2016). A group from Iran studied
cisplatin resistance on ovarian cancer cells (Zendehdel et al.,
2012) by using FTIR spectroscopy. Their results displayed
two main changes parallel with the resistant cancer cells:
the increase in the β-sheets in protein secondary structures
and a shift towards higher wavenumbers of CH2 bands
which is ascribed to the condensation of the aliphatic
chains in the fatty acids of phospholipids of the cancer
cell membranes. In our study, we did not consider protein
secondary structural changes which possibly occur due to
endoplasmic reticulum stress which was shown to play an
important role in cisplatin resistance in oral cancer cells
(Chen et al., 2020). β-sheets are known to occur from
α-helices in the protein aggregation studies as a result of
ER stress and unfolded protein response (Hamdan et al.,
2017). In the present study, we report the metabolic and
macromolecular structural changes in cisplatin-treated

and DR5-AS knockdown HeLa cells. We further show for
the first time that DR5-AS lncRNA accounts for some of
the cisplatin-mediated metabolic and macromolecular
changes in HeLa cells by exploiting FTIR spectroscopy and
transcriptome analyses.
Transcriptome analyses are also widely used to
gain molecular insight into metabolic and cellular
changes. For example, RNA-seq analyses of cisplatin
and phenanthriplatin were conducted in A549 nonsmall
cell lung cancer cells to uncover the most affected
biological processes (Monroe et al., 2020). In this study,
the authors primarily focused on apoptosis, cytoskeleton,
cell migration, and proliferation. Although we observed
a similar expression pattern in HeLa cells of several
genes, such as ATF3, CDKN1A, GADD45A, and FDXR,
our analyses highlighted metabolism as one of the most
affected biological processes (Figure 2C). Another RNA-
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Figure 4. Common metabolic gene expression pattern in cisplatin-treated and DR5-AS knockdown HeLa cells. The GSE160227 RNA-seq data of DR5-AS knockdown cells were
reanalyzed to have count matrix with featureCounts in conda environment. Count matrix was further processed by DESeq2 and (A) Heatmap of top 1000 DEGs was generated
with pheatmap package in R. (B) Reactome pathway analysis of signal transduction pathways in DR5-AS knockdown cells was performed with genes associated with metabolic
pathways. (C) Venn diagram of metabolism-related DEGs in DR5-AS knockdown and cisplatin-treated HeLa cells. (D) qPCR analyses of metabolism-related genes differentially
expressed in DR5-AS knockdown HeLa cells. 1000 ng RNA was used for cDNA synthesis and GAPDH was used for normalization. ns: nonsignificant, p > 0.05, *: p ≤ 0.05, **: p ≤
0.01, ***: p ≤ 0.001, ****: p ≤ 0.0001.
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seq analysis was conducted on cisplatin-resistant HeLa cells
to explore gene expression patterns associated with DNA
methylation and drug resistance (Zeller et al., 2012). Both
studies disregarded cisplatin-induced gene expression
patterns associated with cancer cell metabolism.
Although it is evident that several key protein-coding
genes play an instrumental role in orchestrating cancer
cell metabolism (Martínez-Reyes and Chandel 2021), the
vital role of lncRNAs in this process is emerging recently
(Ghafouri-Fard et al., 2020). Both oncogenic and tumor
suppressor lncRNAs might regulate cancer cell metabolism.
For example, HOTAIR was reported to promote cancer
cell energy metabolism in pancreatic adenocarcinoma by
upregulating hexokinase-2 (Ma et al., 2019). NEF lncRNA,
which is downregulated in NSCLC tissues, targets glucose
transportations to modulate lung tumorigenesis (Chang et
al., 2019). Recently, we reported changes in the abundance
of numerous lncRNAs in cisplatin-treated HeLa cells and
DR5-AS appears to account for some of the cisplatininduced cellular phenotypes (Gurer et al., 2021). It is
interesting that although DR5-AS is a cisplatin-inducible
lncRNA (Gurer et al., 2021), its knockdown in the absence
of cisplatin also generates a cisplatin-like phenotype
(Figure 3B). This observation suggests that DR5-AS could
be a prosurvival lncRNA expressed under stress conditions
(e.g., cisplatin treatment). However, more studies are
required to delineate the molecular function of DR5-AS.
As a modulator of cell proliferation and metastasis, DR5AS appears to modulate HeLa cell metabolism as evident
by the differential expression of numerous metabolic genes
upon DR5-AS knockdown (Figure 4A). Interestingly, a
great fraction of these metabolic genes (Figure 5C, 185
out of 256 genes) is differentially expressed upon cisplatintreatment as well, suggesting that DR5-AS could be used
as a drug target to modulate HeLa cell metabolism. DR5AS is expressed in Jurkat cells and is inducible by cisplatin
to a greater extent compared to HeLa cells (Gurer et al.,
2021). It would be interesting to examine whether DR5AS is a general modulator of cancer cell metabolism or
specific to HeLa cells.
Our transcriptome analyses correlated well with FTIR
analyses. For example, we monitored a 6.75% and 76.6%
decrease in the intensity of the band around 3006 cm–1
in cisplatin-treated and DR5-AS knockdown HeLa cells,
respectively (Figures 1D–1E; Figures 3D–3E). As this
band is an indicator of =CH stretching vibrations of lipids
(Severcan et al., 2005) and potential lipid peroxidation
events, we postulate that the decrease in the unsaturation
of the lipids corresponds to an increase in the saturation
status and antioxidant response of the cells. SLC25A27
(a.k.a Uncoupling Protein 4, UCP4), which, uncouples
oxidation of substrates from ADP phosphorylation in
mitochondria by modulating membrane potential, is a

prognostic marker in breast cancer (Gonidi et al., 2011;
Lytovchenko and Kunji 2017). Interestingly, we detected
a 4.3-fold decrease in the expression of SLC25A27 in
cisplatin-treated and DR5-AS knockdown HeLa cells
(Supplementary Table 3) and a 3.2-fold decrease in the
expression of UCP3 as the other important mitochondrial
protein that plays important roles in the mitochondrial
ROS metabolism. Metabolic changes in cisplatin-treated
and DR5-AS knockdown HeLa cells also included an
increase in the lipid/protein ratio (Figures 1D–1E; Figures
3D–3E). This could be attained by an increase in the total
amount of lipids or a decrease in protein content or a
combination of both. The decrease in the expression of
ACADS transcription suggests a decrease in fatty acid
oxidation as this enzyme is one of the earlier enzymes
involved in this enzymatic cascade (Camões et al., 2015).
The decrease in mitochondrial metabolism is further
supported by the increase in the expression of SNAI1.
Similarly, the decreases observed in the expression of
ACACB and HMGCS1 genes as key players in the synthesis
of two important members of neutral lipids indicate a
potential reduction in the neutral lipid synthetic pathways.
FTIR analyses were supported by gene expression analyses
as the metabolism of proteins and lipids are the most
affected metabolic activities upon cisplatin treatment
(Figure 2D). Strikingly, the expression of several genes was
deregulated, such as HSD3B7, CDS1, ACSL1, HMGCS1,
OSBPL10, and CYP1A1, which are associated with lipid
storage and cholesterol metabolism. In addition to the
neutral lipid biosynthetic and catabolic pathways, both
cisplatin treatment and DR5-AS knockdown suggest a
decrease in the lipid unsaturation thought to be mediated
by a decrease in the SCD5 expression. The decrease in lipid
unsaturation could be a way to remedy the toxic effects of
cisplatin treatment.
All of these observations are further supported by
the finding that the majority of differentially expressed
metabolic genes are primarily associated with the PI3KAkt pathway, which is known to modulate cancer cell
metabolism (Hoxhaj and Manning 2020). Our gene
expression analyses suggest that cisplatin treatment
suppresses the PI3K-Akt pathway (Figure 2), which is in
agreement with previous studies (Zhang et al., 2016; Gohr
et al., 2017; Lin et al., 2017). Suppression of the PI3K-Akt
pathway could potentially decrease the amount of related
enzymes such as FOXO via PI3K-akt-FOXO pathway.
The PI3K/AKT/FOXO axis is also known to inhibit
fatty oxidation within the cancer cell metabolism (Link
and Fernandez-Marcos 2017). It would be interesting to
examine whether reduced levels of ITPRs are associated
with diminished levels of calcium release from ER and
calcium uptake by mitochondria as such events might lead
to lower levels of apoptosis and oxidative stress (Bánsághi
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et al., 2014). In fact, inhibition of the PI3K-Akt pathway
is employed to sensitize cancer cells to treatment with
cisplatin (Zhang et al., 2016; Gohr et al., 2017). To this
extent, DR5-AS knockdown could be a potential avenue
for cancer treatment by sensitizing cells to cisplatinmediated cell death by inactivating the PI3K-Akt pathway.
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Supplementary Figure

Supplementary Figure 1. MA plot for read counts (A) shows RNAseq analysis of 80 uM cisplatin treated HeLa cells. X axis shows the
normalized mean and Y axis indicates log2 fold change values. Red points correspond to significant genes (FDR, padj < 0.05) while
grey points indicate non-significant ones. Positive area above middle line (light red) shows upregulated genes and the negative area have
downregulated genes. Pearson’s Correlation scatterplot shows the relationship between CP and DR5-AS knockdown RNAseq datasets.
Pearson’s r coefficient 0.72 indicates positive moderate correlation between two samples.
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